Sequencing
Private Company
Funding information not available
Overview
Founded in 2014, Sequencing.com operates at the intersection of consumer genetics, digital health, and personalized medicine. Its business model centers on selling at-home WGS kits, offering one-time comprehensive health reports, and generating recurring revenue through an optional subscription service for monthly report updates. The company differentiates itself through its commitment to full-genome sequencing (30x coverage), robust data privacy, and a platform that allows users to upload existing DNA data from other services. While it serves the wellness and ancestry markets, its primary focus is on actionable health insights for disease risk, pharmacogenomics, rare conditions, and family planning.
Technology Platform
Whole Genome Sequencing (30x coverage) platform with continuous bioinformatic reanalysis and a privacy-focused data management system for generating personalized health reports.
Opportunities
Risk Factors
Competitive Landscape
Operates in the competitive D2C genetic testing market, competing against giants like 23andMe and AncestryDNA which use cheaper SNP chips. Differentiates through clinical-grade Whole Genome Sequencing, a strong privacy guarantee, and a subscription-based continuous analysis model, targeting a premium, health-focused consumer segment.